Seelos Therapeutics, Inc.

CIK 1017491 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Seelos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 29, 2025SEC STAFF ACTION9999999997-25-003694
Apr 4, 202525-NSE0001354457-25-000282
Feb 14, 2025SCHEDULE 13G0001595888-25-000074
Feb 14, 2025SCHEDULE 13G/A0000929638-25-000809
Dec 4, 2024SC 13G/A0000929638-24-004157
Nov 25, 2024SCHEDULE 13G0001310379-24-000002
Nov 22, 20248-K0001099910-24-000383
Nov 22, 2024NT 10-Q0001099910-24-000384
Nov 14, 2024SC 13G/A0000929638-24-003937
Nov 5, 2024SC 13G0000929638-24-003740
Oct 24, 20248-K0001104659-24-111155
Oct 24, 2024DEFA14A0001104659-24-111162
Oct 15, 20248-K0001104659-24-108396
Oct 7, 20248-K0001104659-24-106406
Sep 26, 20248-K0001104659-24-103143
Sep 26, 2024DEFA14A0001104659-24-103145
Sep 25, 20248-K0001104659-24-102625
Sep 25, 2024S-10001104659-24-102540
Sep 24, 20248-K0001104659-24-102434
Sep 3, 20248-K0001104659-24-096067
Aug 23, 2024EFFECT9999999995-24-002619
Aug 20, 2024ARS0001140361-24-037918
Aug 20, 2024DEF 14A0001140361-24-037913
Aug 16, 2024S-30001104659-24-090488
Aug 14, 202410-Q0001410578-24-001435